T1	Participants 79 117	patients with type 2 diabetes mellitus
T2	Participants 280 418	multicentre, randomized, double-blind, placebo-controlled, 4-week study in patients with type 2 diabetes with suboptimal metabolic control
T3	Participants 420 504	Patients with a baseline haemoglobin A(1c) (HbA(1c)) of 7.3 to 11.0% were randomized
